Why is NeuroMetrix stock trading higher today?
The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA. NeuroMetrix shares are trading higher after the company announced its Quell technology received Breakthrough Designation from the FDA for reducing moderate to severe symptoms of chemotherapy induced peripheral neuropathy. - Benzinga
How much is a Nuro stock worth?
One share of NURO stock can currently be purchased for approximately $4.25. How much money does NeuroMetrix make? NeuroMetrix has a market capitalization of $28.37 million and generates $8.25 million in revenue each year. The medical device company earns $-2.28 million in net income (profit) each year or ($0.42) on an earnings per share basis.
How much does NeuroMetrix make a year?
NeuroMetrix has a market capitalization of $28.37 million and generates $8.25 million in revenue each year. The medical device company earns $-2.28 million in net income (profit) each year or ($0.42) on an earnings per share basis. How many employees does NeuroMetrix have?
Where is NeuroMetrix located?
It operates in the United States, Europe, Asia, the Middle East, Mexico, and internationally. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
When will NeuroMetrix release its results?
How much is NeuroMetrix's net loss in 2021?
What is NeuroMetrix 2021?
When is NeuroMetrix earnings call 2021?
Is NeuroMetrix a high volume stock?
See more
About this website
What is going on with Nuro stock?
NeuroMetrix Inc (NASDAQ:NURO) The 1 analysts offering 12-month price forecasts for NeuroMetrix Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 50.00. The median estimate represents a +1,240.48% increase from the last price of 3.73.
Is Nuro a good stock to buy?
Is Neurometrix Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: NURO) stock is to Strong Buy NURO stock.
Is Nuro stock publicly traded?
Nuro does not currently have an official ticker symbol because this company is still private.
What is the stock symbol for Nuro robotics?
Stock Quote (U.S.: Nasdaq) | MarketWatch....$ 3.4500.CloseChgChg %$3.30000.01000.30%
Is Nuro a private company?
Nuro is an American robotics company based in Mountain View, California and founded by Jiajun Zhu and Dave Ferguson....Nuro.TypePrivateNumber of employees800+Websitenuro.ai4 more rows
Why did Nuro stock go up today?
NeuroMetrix (NASDAQ:NURO) stock is rocketing higher on Tuesday thanks to the U.S. Food and Drug Administration (FDA) granting it Breakthrough Designation for one of its devices.
Does Nuro go IPO?
There have been no plans from the company to participate in the Nuro IPO.
Can I buy Neuralink stock?
There is no minimum order limit. You can invest in the tokenized shares of Neuralink or any other company listed on the exchange with as little as $1. And the company will convert your funds to parts of a whole share.
Who owns Nuro stock?
Top 10 Owners of NeuroMetrix IncStockholderStakeShares ownedThe Vanguard Group, Inc.4.39%312,788Geode Capital Management LLC0.76%53,905BlackRock Fund Advisors0.53%38,050Renaissance Technologies LLC0.42%30,1286 more rows
How many shares does Nuro have?
Share StatisticsAvg Vol (3 month) 31.69MShares Outstanding 57.13MImplied Shares Outstanding 6N/AFloat 86.46M% Held by Insiders 11.42%7 more rows
What is Argo AI stock symbol?
Stock Quote (U.S.: NYSE) | MarketWatch....$ 33.51.CloseChgChg %$33.510.150.45%
How many patents does Nuro?
111 patentsThe startup has 111 patents in its portfolio that belong to 21 patent families. Below are the key highlights of Nuro's patents.
Who owns Nuro stock?
Top 10 Owners of NeuroMetrix IncStockholderStakeShares ownedThe Vanguard Group, Inc.4.39%312,788Geode Capital Management LLC0.76%53,905BlackRock Fund Advisors0.53%38,050Renaissance Technologies LLC0.42%30,1286 more rows
Why is NeuroMetrix stock dropping?
NeuroMetrix Inc. shares on Friday fell 17% to $4.58, a day after the company said the Food and Drug Administration gave De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity.
Is Nuro a real vehicle?
Nuro is one of the few US companies to be operating fully driverless vehicles — that is, vehicles without safety drivers behind the wheel — on public roads today. Its R2 vehicle is about half as wide as a compact sedan, shorter than most cars, and there's no room inside for human passengers or drivers.
Who funded Nuro?
Tiger Global ManagementThe funding round, led by Tiger Global Management, lifted Nuro's valuation to $8.6 billion from $5 billion previously, according to a person close to the deal. Toyota Motor Corp's (7203. T) Woven Capital, SoftBank Group Corp's (9984. T) Vision Fund 1, Kroger Co.
Buy or sell Nuro stock pre IPO via an EquityZen fund
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Invest or Sell Nuro Stock - Forge Global
Nuro is the a provider of autonomous delivery using robotics with a fleet of on-road, fully occupantless and autonomous vehicles designed to deliver everyday goods to consumers ranging from groceries to pizza to prescriptions in a way that is quick, affordable, and most importantly, safe.
NURO Neurometrix Inc. — Stock Price and Discussion | Stocktwits
Real-time trade and investing ideas on Neurometrix Inc. NURO from the largest community of traders and investors.
NeuroMetrix, Inc. Common Stock (NURO) Stock Price, Quote, News ...
NeuroMetrix, Inc. Common Stock (NURO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
What is neurometrix?
What time do you trade in the pre market?
NeuroMetrix Inc is a commercial stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stim
Does market cap include convertible securities?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
What is the ticker symbol for NeuroMetrix?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
What is a neurometrix?
NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."
What is the P/E ratio of NeuroMetrix?
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
When did NeuroMetrix reverse split?
The P/E ratio of NeuroMetrix is -23.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
When did the 1-8 reverse split happen?
Shares of NeuroMetrix reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.
Is there enough data for NeuroMetrix?
The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.
Does NeuroMetrix pay dividends?
There is not enough analysis data for NeuroMetrix.
When will NeuroMetrix release its results?
NeuroMetrix does not currently pay a dividend.
How much is NeuroMetrix's net loss in 2021?
(Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on April 22, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on April 22, 2021 to discuss its financial results as well as business developments affecting the Company. The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation code 9554608. Internationally, the conference call may be accessed by dialing 661-378-9630 and using the same confirmation code. The earnings press release and accompanying condensed financial statements will be accessible from the Company's website at www.NeuroMetrix.com under the "Investor Relations" tab. A replay of the conference call will be available starting two hours after the call by dialing 855-859-2056, domestically and 404-537-3406, internationally. The confirmation code to access the replay is 9554608. The replay will be available for one week after the conference call. About NeuroMetrix NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for symptomatic relief of chronic pain that is available over-the-counter. For more information, visit www.NeuroMetrix.com. NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief Financial [email protected] Source: NeuroMetrix, Inc.
What is NeuroMetrix 2021?
The Q1 2021 net loss of $60 thousand, or $0.02 per share, compares favorably with the net loss of $657 thousand, or $0.45 per share, in Q1 2020. Company to Host Live Conference Call and Webcast NeuroMetrix will host a conference call at 8:00 a.m. Eastern today, April 22, 2021.
When is NeuroMetrix earnings call 2021?
(Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Highlights: Revenue of $2.1 million was up slightly from Q3 2020. Gross margin on revenue was $1.4 million, a 70.0% gross margin rate. This was a decrease of 3.6 percentage points from $1.5 m
Is NeuroMetrix a high volume stock?
NEW YORK, NY / ACCESSWIRE / April 22, 2021 / NeuroMetrix, Inc. (NASDAQ:NURO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 22, 2021 at 8:00 AM Eastern Time.
